<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00592475</url>
  </required_header>
  <id_info>
    <org_study_id>087-CL-089</org_study_id>
    <secondary_id>2007-001661-15</secondary_id>
    <nct_id>NCT00592475</nct_id>
  </id_info>
  <brief_title>A Study to Assess the Safety and Effects of Intravenous (IV) Conivaptan on the Hepatic Hemodynamic Response in Cirrhotic Patients</brief_title>
  <official_title>A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Escalation Study to Assess the Safety and Effects of Intravenous Conivaptan on the Hepatic Hemodynamic Response in Stable Euvolemic or Hypervolemic Cirrhotic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cumberland Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cumberland Pharmaceuticals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety of IV conivaptan in stable euvolemic or hypervolemic cirrhotic
      patients, and to characterize the effects of IV conivaptan on the hepatic hemodynamic
      response in patients with cirrhosis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2007</start_date>
  <completion_date type="Actual">November 2008</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Hepatic Venous Pressure Gradient (HVPG) at 0.5, 1, and 1.5 Hours Post Dose</measure>
    <time_frame>Baseline and 0.5, 1, and 1.5 hours post dose</time_frame>
    <description>Change from baseline is calculated as time point minus baseline.
Baseline procedures were performed prior to study drug administration.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Hepatic Blood Flow (HBF) at 0.5, 1, and 1.5 Hours Post Dose</measure>
    <time_frame>Baseline and 0.5, 1, and 1.5 hours post dose</time_frame>
    <description>Change from baseline is calculated as time point minus baseline.
Baseline procedures were performed prior to study drug administration.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Hepatic Mean Arterial Pressure (MAP) at 0.5, 1, and 1.5 Hours Post Dose</measure>
    <time_frame>Baseline and 0.5, 1, and 1.5 hours post dose</time_frame>
    <description>Change from baseline is calculated as time point minus baseline.
Baseline procedures were performed prior to study drug administration.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Blood Pressure at 0.5, 1, 1.5, 2.5, 3.5, 4.5, 5.5, 6.5, 9, 12, and 24 Hours, and Day 8 Post Dose</measure>
    <time_frame>Baseline and 0.5, 1, 1.5, 2.5, 3.5, 4.5, 5.5, 6.5, 9, 12, and 24 hours, and Day 8 post dose</time_frame>
    <description>Change from baseline is calculated as time point minus baseline.
Baseline procedures were performed prior to study drug administration.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Heart Rate at 0.5, 1, 1.5, 2.5, 3.5, 4.5, 5.5, 6.5, 9, 12, and 24 Hours, and Day 8 Post Dose</measure>
    <time_frame>Baseline and 0.5, 1, 1.5, 2.5, 3.5, 4.5, 5.5, 6.5, 9, 12, and 24 hours, and Day 8 post dose</time_frame>
    <description>Change from baseline is calculated as time point minus baseline.
Baseline procedures were performed prior to study drug administration.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Serum Sodium Levels at 0.5, 1, 2.5, 4, 6.5, 9, 12, and 24 Hours and on Day 8 Post Dose</measure>
    <time_frame>Baseline and 0.5, 1, 2.5, 4, 6.5, 9, 12, and 24 hours and on Day 8 post dose</time_frame>
    <description>Baseline serum sodium value is the last measurement prior to dosing.
Change from baseline is calculated as time point minus baseline.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Liver Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Regimen 1 Conivaptan 12.5 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Conivaptan intravenous loading dose (10 mg) + 2.5 mg continuous infusion over 6.5 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Regimen 2 Conivaptan 25 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Conivaptan intravenous loading dose (20 mg) + 5 mg continuous infusion over 6.5 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Regimen 3 Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo continuous intravenous infusion over 6.5 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>conivaptan</intervention_name>
    <description>IV</description>
    <arm_group_label>Regimen 1 Conivaptan 12.5 mg</arm_group_label>
    <arm_group_label>Regimen 2 Conivaptan 25 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>IV</description>
    <arm_group_label>Regimen 3 Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Institutional Review Board (IRB)/Independent Ethics Committee (IEC)-approved written
             Informed Consent and appropriate privacy language as per national regulations must be
             obtained from the subject or legally authorized representative prior to any
             study-related procedures (including withdrawal of prohibited medication, if
             applicable)

          -  Subject is euvolemic or hypervolemic (edematous) secondary to cirrhosis

          -  Subject has clinical evidence of portal hypertension by the presence of esophageal
             varices, ascites or both

        Exclusion Criteria:

          -  Clinical evidence of volume depletion or dehydration

          -  Subject has a history of bleeding from esophageal varices within three months before
             the start of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Art Wheeler, MD</last_name>
    <role>Study Director</role>
    <affiliation>Cumberland Pharmaceuticals Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://www.astellas.us/docs/vaprisol.pdf</url>
    <description>(Link to Prescribing Information)</description>
  </link>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 2, 2008</study_first_submitted>
  <study_first_submitted_qc>January 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2008</study_first_posted>
  <results_first_submitted>May 24, 2010</results_first_submitted>
  <results_first_submitted_qc>September 8, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 28, 2010</results_first_posted>
  <last_update_submitted>April 30, 2014</last_update_submitted>
  <last_update_submitted_qc>April 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 15, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>conivaptan</keyword>
  <keyword>Liver Cirrhosis</keyword>
  <keyword>Hypertension, Portal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Conivaptan</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Regimen 1 Conivaptan 12.5 mg</title>
          <description>Conivaptan intravenous loading dose (10 mg) + 2.5 mg continuous infusion over 6.5 hours</description>
        </group>
        <group group_id="P2">
          <title>Regimen 2 Conivaptan 25 mg</title>
          <description>Conivaptan intravenous loading dose (20 mg) + 5 mg continuous infusion over 6.5 hours</description>
        </group>
        <group group_id="P3">
          <title>Regimen 3 Placebo</title>
          <description>Placebo continuous intravenous infusion over 6.5 hours</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Regimen 1 Conivaptan 12.5 mg</title>
          <description>Conivaptan intravenous loading dose (10 mg) + 2.5 mg continuous infusion over 6.5 hours</description>
        </group>
        <group group_id="B2">
          <title>Regimen 2 Conivaptan 25 mg</title>
          <description>Conivaptan intravenous loading dose (20 mg) + 5 mg continuous infusion over 6.5 hours</description>
        </group>
        <group group_id="B3">
          <title>Regimen 3 Placebo</title>
          <description>Placebo continuous intravenous infusion over 6.5 hours</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="5"/>
            <count group_id="B4" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.7" spread="8.52"/>
                    <measurement group_id="B2" value="60.0" spread="9.72"/>
                    <measurement group_id="B3" value="55.2" spread="7.19"/>
                    <measurement group_id="B4" value="59.9" spread="8.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Underlying Cause of Hyponatremia</title>
          <description>Patients in the “Not hyponatremia” categories had serum sodium levels of 135-140mEq/L.
Patients in the “Other” categories had Diuretic treatment.</description>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Euvolemic - Cirrhosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Euvolemic - Not Hyponatremia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Euvolemic - Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypervolemic - Cirrhosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypervolemic - Not Hyponatremia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypervolemic - Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Hepatic Venous Pressure Gradient (HVPG) at 0.5, 1, and 1.5 Hours Post Dose</title>
        <description>Change from baseline is calculated as time point minus baseline.
Baseline procedures were performed prior to study drug administration.</description>
        <time_frame>Baseline and 0.5, 1, and 1.5 hours post dose</time_frame>
        <population>Participants Analyzed represents Full Analysis Set (FAS): All randomized patients who had at least 1 dose of study drug &amp; who had hepatic venous pressure gradient data at baseline.
The number of participants per arm is consistent for all categories of the data table.</population>
        <group_list>
          <group group_id="O1">
            <title>Regimen 1 Conivaptan 12.5 mg</title>
            <description>Conivaptan intravenous loading dose (10 mg) + 2.5 mg continuous infusion over 6.5 hours</description>
          </group>
          <group group_id="O2">
            <title>Regimen 2 Conivaptan 25 mg</title>
            <description>Conivaptan intravenous loading dose (20 mg) + 5 mg continuous infusion over 6.5 hours</description>
          </group>
          <group group_id="O3">
            <title>Regimen 3 Placebo</title>
            <description>Placebo continuous intravenous infusion over 6.5 hours</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Hepatic Venous Pressure Gradient (HVPG) at 0.5, 1, and 1.5 Hours Post Dose</title>
          <description>Change from baseline is calculated as time point minus baseline.
Baseline procedures were performed prior to study drug administration.</description>
          <population>Participants Analyzed represents Full Analysis Set (FAS): All randomized patients who had at least 1 dose of study drug &amp; who had hepatic venous pressure gradient data at baseline.
The number of participants per arm is consistent for all categories of the data table.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.58" spread="4.375"/>
                    <measurement group_id="O2" value="18.33" spread="4.750"/>
                    <measurement group_id="O3" value="15.80" spread="6.601"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 0.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.33" spread="1.080"/>
                    <measurement group_id="O2" value="0.11" spread="1.318"/>
                    <measurement group_id="O3" value="-0.10" spread="0.224"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 1 Hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.50" spread="1.844"/>
                    <measurement group_id="O2" value="0.56" spread="1.357"/>
                    <measurement group_id="O3" value="-0.60" spread="0.418"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 1.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.83" spread="2.113"/>
                    <measurement group_id="O2" value="0.83" spread="1.732"/>
                    <measurement group_id="O3" value="-0.10" spread="1.294"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Hepatic Blood Flow (HBF) at 0.5, 1, and 1.5 Hours Post Dose</title>
        <description>Change from baseline is calculated as time point minus baseline.
Baseline procedures were performed prior to study drug administration.</description>
        <time_frame>Baseline and 0.5, 1, and 1.5 hours post dose</time_frame>
        <population>Participants Analyzed represents FAS: All randomized patients who had at least 1 dose of study drug &amp; who had hepatic venous pressure gradient data at baseline. (Note: 2 patients were not included in the analysis due to protocol deviations.) The number of participants included in the calculation for each timepoint is noted in the category title.</population>
        <group_list>
          <group group_id="O1">
            <title>Regimen 1 Conivaptan 12.5 mg</title>
            <description>Conivaptan intravenous loading dose (10 mg) + 2.5 mg continuous infusion over 6.5 hours</description>
          </group>
          <group group_id="O2">
            <title>Regimen 2 Conivaptan 25 mg</title>
            <description>Conivaptan intravenous loading dose (20 mg) + 5 mg continuous infusion over 6.5 hours</description>
          </group>
          <group group_id="O3">
            <title>Regimen 3 Placebo</title>
            <description>Placebo continuous intravenous infusion over 6.5 hours</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Hepatic Blood Flow (HBF) at 0.5, 1, and 1.5 Hours Post Dose</title>
          <description>Change from baseline is calculated as time point minus baseline.
Baseline procedures were performed prior to study drug administration.</description>
          <population>Participants Analyzed represents FAS: All randomized patients who had at least 1 dose of study drug &amp; who had hepatic venous pressure gradient data at baseline. (Note: 2 patients were not included in the analysis due to protocol deviations.) The number of participants included in the calculation for each timepoint is noted in the category title.</population>
          <units>mL/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (N= 4; 9; 5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="581.0" spread="77.49"/>
                    <measurement group_id="O2" value="1182.2" spread="530.56"/>
                    <measurement group_id="O3" value="649.6" spread="300.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 0.5 Hours (N= 4; 9; 5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.5" spread="161.30"/>
                    <measurement group_id="O2" value="-74.1" spread="558.58"/>
                    <measurement group_id="O3" value="73.8" spread="196.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 1 Hour (N= 4; 9; 4)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="160.23"/>
                    <measurement group_id="O2" value="-70.0" spread="318.35"/>
                    <measurement group_id="O3" value="-67.5" spread="270.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 1.5 Hours (N= 4; 9; 5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.8" spread="60.26"/>
                    <measurement group_id="O2" value="-96.0" spread="390.96"/>
                    <measurement group_id="O3" value="40.8" spread="154.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Hepatic Mean Arterial Pressure (MAP) at 0.5, 1, and 1.5 Hours Post Dose</title>
        <description>Change from baseline is calculated as time point minus baseline.
Baseline procedures were performed prior to study drug administration.</description>
        <time_frame>Baseline and 0.5, 1, and 1.5 hours post dose</time_frame>
        <population>Participants Analyzed represents FAS: All randomized patients who had at least 1 dose of study drug &amp; who had hepatic venous pressure gradient data at baseline.
The number of participants included in the calculation for each timepoint is noted in the category title.</population>
        <group_list>
          <group group_id="O1">
            <title>Regimen 1 Conivaptan 12.5 mg</title>
            <description>Conivaptan intravenous loading dose (10 mg) + 2.5 mg continuous infusion over 6.5 hours</description>
          </group>
          <group group_id="O2">
            <title>Regimen 2 Conivaptan 25 mg</title>
            <description>Conivaptan intravenous loading dose (20 mg) + 5 mg continuous infusion over 6.5 hours</description>
          </group>
          <group group_id="O3">
            <title>Regimen 3 Placebo</title>
            <description>Placebo continuous intravenous infusion over 6.5 hours</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Hepatic Mean Arterial Pressure (MAP) at 0.5, 1, and 1.5 Hours Post Dose</title>
          <description>Change from baseline is calculated as time point minus baseline.
Baseline procedures were performed prior to study drug administration.</description>
          <population>Participants Analyzed represents FAS: All randomized patients who had at least 1 dose of study drug &amp; who had hepatic venous pressure gradient data at baseline.
The number of participants included in the calculation for each timepoint is noted in the category title.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (N= 6; 9; 5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.3" spread="11.89"/>
                    <measurement group_id="O2" value="90.3" spread="7.79"/>
                    <measurement group_id="O3" value="84.6" spread="13.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 0.5 Hours (N= 6; 8; 5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.2" spread="9.66"/>
                    <measurement group_id="O2" value="3.6" spread="9.97"/>
                    <measurement group_id="O3" value="2.6" spread="4.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 1.0 Hour (N= 6; 9; 5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.2" spread="9.28"/>
                    <measurement group_id="O2" value="5.7" spread="13.18"/>
                    <measurement group_id="O3" value="7.8" spread="10.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 1.5 Hours (N= 6; 9; 5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="7.77"/>
                    <measurement group_id="O2" value="8.8" spread="11.39"/>
                    <measurement group_id="O3" value="3.4" spread="6.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Blood Pressure at 0.5, 1, 1.5, 2.5, 3.5, 4.5, 5.5, 6.5, 9, 12, and 24 Hours, and Day 8 Post Dose</title>
        <description>Change from baseline is calculated as time point minus baseline.
Baseline procedures were performed prior to study drug administration.</description>
        <time_frame>Baseline and 0.5, 1, 1.5, 2.5, 3.5, 4.5, 5.5, 6.5, 9, 12, and 24 hours, and Day 8 post dose</time_frame>
        <population>Population is Safety Analysis Set (SAF): All randomized patients who received at least one dose of study medication.
The number of participants per arm is consistent for all categories of the data table.</population>
        <group_list>
          <group group_id="O1">
            <title>Regimen 1 Conivaptan 12.5 mg</title>
            <description>Conivaptan intravenous loading dose (10 mg) + 2.5 mg continuous infusion over 6.5 hours</description>
          </group>
          <group group_id="O2">
            <title>Regimen 2 Conivaptan 25 mg</title>
            <description>Conivaptan intravenous loading dose (20 mg) + 5 mg continuous infusion over 6.5 hours</description>
          </group>
          <group group_id="O3">
            <title>Regimen 3 Placebo</title>
            <description>Placebo continuous intravenous infusion over 6.5 hours</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Blood Pressure at 0.5, 1, 1.5, 2.5, 3.5, 4.5, 5.5, 6.5, 9, 12, and 24 Hours, and Day 8 Post Dose</title>
          <description>Change from baseline is calculated as time point minus baseline.
Baseline procedures were performed prior to study drug administration.</description>
          <population>Population is Safety Analysis Set (SAF): All randomized patients who received at least one dose of study medication.
The number of participants per arm is consistent for all categories of the data table.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Systolic Blood Pressure- Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="112.2" spread="13.73"/>
                    <measurement group_id="O2" value="115.0" spread="14.42"/>
                    <measurement group_id="O3" value="112.8" spread="12.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systolic Blood Pressure- Change at 0.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.3" spread="13.29"/>
                    <measurement group_id="O2" value="5.2" spread="9.86"/>
                    <measurement group_id="O3" value="12.8" spread="17.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systolic Blood Pressure- Change at 1 Hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.5" spread="17.62"/>
                    <measurement group_id="O2" value="13.9" spread="14.12"/>
                    <measurement group_id="O3" value="6.8" spread="21.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systolic Blood Pressure- Change at 1.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.8" spread="20.90"/>
                    <measurement group_id="O2" value="7.2" spread="12.59"/>
                    <measurement group_id="O3" value="1.2" spread="16.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systolic Blood Pressure- Change at 2.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.5" spread="9.65"/>
                    <measurement group_id="O2" value="-3.8" spread="8.15"/>
                    <measurement group_id="O3" value="-2.6" spread="18.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systolic Blood Pressure- Change at 3.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.0" spread="8.94"/>
                    <measurement group_id="O2" value="-6.3" spread="14.83"/>
                    <measurement group_id="O3" value="-11.4" spread="10.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systolic Blood Pressure- Change at 4.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.2" spread="12.91"/>
                    <measurement group_id="O2" value="-17.1" spread="11.54"/>
                    <measurement group_id="O3" value="-8.2" spread="2.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systolic Blood Pressure- Change at 5.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.3" spread="7.20"/>
                    <measurement group_id="O2" value="-8.7" spread="14.94"/>
                    <measurement group_id="O3" value="-7.6" spread="2.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systolic Blood Pressure- Change at 6.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.8" spread="10.65"/>
                    <measurement group_id="O2" value="-9.7" spread="7.73"/>
                    <measurement group_id="O3" value="-9.4" spread="15.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systolic Blood Pressure- Change at 9 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.5" spread="15.35"/>
                    <measurement group_id="O2" value="1.9" spread="11.46"/>
                    <measurement group_id="O3" value="-7.2" spread="12.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systolic Blood Pressure- Change at 12 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-14.0" spread="21.48"/>
                    <measurement group_id="O2" value="-7.8" spread="15.97"/>
                    <measurement group_id="O3" value="-5.8" spread="19.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systolic Blood Pressure- Change at 24 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-10.8" spread="15.21"/>
                    <measurement group_id="O2" value="-7.8" spread="12.53"/>
                    <measurement group_id="O3" value="-11.0" spread="5.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systolic Blood Pressure- Change at 8 Days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.5" spread="7.87"/>
                    <measurement group_id="O2" value="-7.8" spread="10.87"/>
                    <measurement group_id="O3" value="-5.4" spread="8.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic Blood Pressure- Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.3" spread="10.65"/>
                    <measurement group_id="O2" value="66.3" spread="9.10"/>
                    <measurement group_id="O3" value="71.6" spread="8.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic Blood Pressure- Change at 0.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5" spread="3.27"/>
                    <measurement group_id="O2" value="4.9" spread="6.83"/>
                    <measurement group_id="O3" value="1.8" spread="6.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic Blood Pressure- Change at 1 Hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.3" spread="5.57"/>
                    <measurement group_id="O2" value="5.1" spread="6.45"/>
                    <measurement group_id="O3" value="3.6" spread="9.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic Blood Pressure- Change at 1.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.2" spread="5.04"/>
                    <measurement group_id="O2" value="5.7" spread="7.04"/>
                    <measurement group_id="O3" value="4.0" spread="11.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic Blood Pressure- Change at 2.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="4.83"/>
                    <measurement group_id="O2" value="-2.1" spread="6.21"/>
                    <measurement group_id="O3" value="-3.2" spread="12.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic Blood Pressure- Change at 3.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="2.28"/>
                    <measurement group_id="O2" value="-0.9" spread="12.00"/>
                    <measurement group_id="O3" value="-6.8" spread="5.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic Blood Pressure- Change at 4.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.5" spread="3.27"/>
                    <measurement group_id="O2" value="-6.3" spread="7.45"/>
                    <measurement group_id="O3" value="-6.4" spread="7.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic Blood Pressure- Change at 5.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7" spread="3.93"/>
                    <measurement group_id="O2" value="-4.2" spread="7.79"/>
                    <measurement group_id="O3" value="-9.8" spread="10.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic Blood Pressure- Change at 6.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.0" spread="7.13"/>
                    <measurement group_id="O2" value="-4.7" spread="6.20"/>
                    <measurement group_id="O3" value="-7.6" spread="11.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic Blood Pressure- Change at 9 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" spread="5.62"/>
                    <measurement group_id="O2" value="0.3" spread="4.82"/>
                    <measurement group_id="O3" value="-4.4" spread="10.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic Blood Pressure- Change at 12 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" spread="12.68"/>
                    <measurement group_id="O2" value="-3.3" spread="6.42"/>
                    <measurement group_id="O3" value="-6.0" spread="13.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic Blood Pressure- Change at 24 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.5" spread="7.34"/>
                    <measurement group_id="O2" value="-5.1" spread="5.56"/>
                    <measurement group_id="O3" value="-11.4" spread="10.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic Blood Pressure- Change at 8 Days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.0" spread="6.72"/>
                    <measurement group_id="O2" value="-5.0" spread="9.55"/>
                    <measurement group_id="O3" value="-7.6" spread="7.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Heart Rate at 0.5, 1, 1.5, 2.5, 3.5, 4.5, 5.5, 6.5, 9, 12, and 24 Hours, and Day 8 Post Dose</title>
        <description>Change from baseline is calculated as time point minus baseline.
Baseline procedures were performed prior to study drug administration.</description>
        <time_frame>Baseline and 0.5, 1, 1.5, 2.5, 3.5, 4.5, 5.5, 6.5, 9, 12, and 24 hours, and Day 8 post dose</time_frame>
        <population>Population is Safety Analysis Set (SAF): All randomized patients who received at least one dose of study medication.
The number of participants per arm is consistent for all categories of the data table.</population>
        <group_list>
          <group group_id="O1">
            <title>Regimen 1 Conivaptan 12.5 mg</title>
            <description>Conivaptan intravenous loading dose (10 mg) + 2.5 mg continuous infusion over 6.5 hours</description>
          </group>
          <group group_id="O2">
            <title>Regimen 2 Conivaptan 25 mg</title>
            <description>Conivaptan intravenous loading dose (20 mg) + 5 mg continuous infusion over 6.5 hours</description>
          </group>
          <group group_id="O3">
            <title>Regimen 3 Placebo</title>
            <description>Placebo continuous intravenous infusion over 6.5 hours</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Heart Rate at 0.5, 1, 1.5, 2.5, 3.5, 4.5, 5.5, 6.5, 9, 12, and 24 Hours, and Day 8 Post Dose</title>
          <description>Change from baseline is calculated as time point minus baseline.
Baseline procedures were performed prior to study drug administration.</description>
          <population>Population is Safety Analysis Set (SAF): All randomized patients who received at least one dose of study medication.
The number of participants per arm is consistent for all categories of the data table.</population>
          <units>bpm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.0" spread="19.30"/>
                    <measurement group_id="O2" value="77.3" spread="22.86"/>
                    <measurement group_id="O3" value="72.0" spread="25.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 0.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="8.33"/>
                    <measurement group_id="O2" value="-6.0" spread="11.88"/>
                    <measurement group_id="O3" value="-2.0" spread="8.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 1 Hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" spread="7.92"/>
                    <measurement group_id="O2" value="-5.4" spread="9.25"/>
                    <measurement group_id="O3" value="-2.4" spread="7.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 1.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="8.66"/>
                    <measurement group_id="O2" value="-4.0" spread="9.73"/>
                    <measurement group_id="O3" value="-3.2" spread="8.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 2.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="3.27"/>
                    <measurement group_id="O2" value="-8.6" spread="11.17"/>
                    <measurement group_id="O3" value="0.4" spread="9.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 3.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="7.66"/>
                    <measurement group_id="O2" value="-1.4" spread="14.34"/>
                    <measurement group_id="O3" value="2.8" spread="7.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 4.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="5.65"/>
                    <measurement group_id="O2" value="-1.2" spread="15.81"/>
                    <measurement group_id="O3" value="4.0" spread="7.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 5.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" spread="5.35"/>
                    <measurement group_id="O2" value="-2.9" spread="14.14"/>
                    <measurement group_id="O3" value="3.6" spread="5.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 6.5 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.0" spread="4.56"/>
                    <measurement group_id="O2" value="-4.0" spread="13.08"/>
                    <measurement group_id="O3" value="3.4" spread="7.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 9 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8" spread="10.21"/>
                    <measurement group_id="O2" value="-0.9" spread="12.32"/>
                    <measurement group_id="O3" value="1.8" spread="11.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 12 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="8.84"/>
                    <measurement group_id="O2" value="9.0" spread="21.46"/>
                    <measurement group_id="O3" value="3.8" spread="15.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 24 Hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="6.01"/>
                    <measurement group_id="O2" value="2.7" spread="17.00"/>
                    <measurement group_id="O3" value="3.6" spread="7.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 8 Days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="10.31"/>
                    <measurement group_id="O2" value="-7.1" spread="20.87"/>
                    <measurement group_id="O3" value="-0.8" spread="9.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Serum Sodium Levels at 0.5, 1, 2.5, 4, 6.5, 9, 12, and 24 Hours and on Day 8 Post Dose</title>
        <description>Baseline serum sodium value is the last measurement prior to dosing.
Change from baseline is calculated as time point minus baseline.</description>
        <time_frame>Baseline and 0.5, 1, 2.5, 4, 6.5, 9, 12, and 24 hours and on Day 8 post dose</time_frame>
        <population>Participants Analyzed represents FAS: All randomized patients who had at least 1 dose of study drug &amp; who had hepatic venous pressure gradient data at baseline.
The number of participants included in the calculation for each timepoint is noted in the category title.</population>
        <group_list>
          <group group_id="O1">
            <title>Regimen 1 Conivaptan 12.5 mg</title>
            <description>Conivaptan intravenous loading dose (10 mg) + 2.5 mg continuous infusion over 6.5 hours</description>
          </group>
          <group group_id="O2">
            <title>Regimen 2 Conivaptan 25 mg</title>
            <description>Conivaptan intravenous loading dose (20 mg) + 5 mg continuous infusion over 6.5 hours</description>
          </group>
          <group group_id="O3">
            <title>Regimen 3 Placebo</title>
            <description>Placebo continuous intravenous infusion over 6.5 hours</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Serum Sodium Levels at 0.5, 1, 2.5, 4, 6.5, 9, 12, and 24 Hours and on Day 8 Post Dose</title>
          <description>Baseline serum sodium value is the last measurement prior to dosing.
Change from baseline is calculated as time point minus baseline.</description>
          <population>Participants Analyzed represents FAS: All randomized patients who had at least 1 dose of study drug &amp; who had hepatic venous pressure gradient data at baseline.
The number of participants included in the calculation for each timepoint is noted in the category title.</population>
          <units>mEq/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (N= 6; 9; 5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="137.3" spread="3.08"/>
                    <measurement group_id="O2" value="137.1" spread="2.80"/>
                    <measurement group_id="O3" value="131.2" spread="6.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 0.5 Hours (N= 6; 9; 5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.3" spread="3.01"/>
                    <measurement group_id="O2" value="-1.1" spread="2.71"/>
                    <measurement group_id="O3" value="-0.8" spread="1.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 1 Hour (N= 6; 9; 5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="3.72"/>
                    <measurement group_id="O2" value="0.9" spread="2.80"/>
                    <measurement group_id="O3" value="-1.8" spread="1.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 2.5 Hours (N= 6; 9; 5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="2.56"/>
                    <measurement group_id="O2" value="0.2" spread="1.72"/>
                    <measurement group_id="O3" value="0.0" spread="3.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 4 Hours (N= 6; 9; 5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.2" spread="5.19"/>
                    <measurement group_id="O2" value="-1.0" spread="1.87"/>
                    <measurement group_id="O3" value="-3.6" spread="1.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 6.5 Hours (N= 6; 9; 5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.2" spread="2.32"/>
                    <measurement group_id="O2" value="1.3" spread="4.33"/>
                    <measurement group_id="O3" value="-2.4" spread="2.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 9 Hours (N= 5; 9; 5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.6" spread="3.05"/>
                    <measurement group_id="O2" value="0.8" spread="3.46"/>
                    <measurement group_id="O3" value="-2.4" spread="2.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 12 Hours (N= 6; 9; 5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.7" spread="2.66"/>
                    <measurement group_id="O2" value="0.1" spread="3.06"/>
                    <measurement group_id="O3" value="-2.2" spread="2.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 24 Hours (N= 6; 9; 5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.5" spread="2.88"/>
                    <measurement group_id="O2" value="0.1" spread="1.76"/>
                    <measurement group_id="O3" value="-2.0" spread="3.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 8 Days (N= 6; 9; 5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.3" spread="3.20"/>
                    <measurement group_id="O2" value="0.1" spread="3.59"/>
                    <measurement group_id="O3" value="2.0" spread="1.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Treatment-Emergent Adverse Event (TEAE) is an event that occurred after the first dose of study drug through 24 hours after the last dose of study drug.</desc>
      <group_list>
        <group group_id="E1">
          <title>Regimen 1 Conivaptan 12.5 mg</title>
          <description>Conivaptan intravenous loading dose (10 mg) + 2.5 mg continuous infusion over 6.5 hours</description>
        </group>
        <group group_id="E2">
          <title>Regimen 2 Conivaptan 25 mg</title>
          <description>Conivaptan intravenous loading dose (20 mg) + 5 mg continuous infusion over 6.5 hours</description>
        </group>
        <group group_id="E3">
          <title>Regimen 3 Placebo</title>
          <description>Placebo continuous intravenous infusion over 6.5 hours</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (9.1)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (9.1)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Polydipsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Productive cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dry skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Institute and/or Principal Investigator may publish trial data generated from the Study. Sponsor must receive the manuscript 60 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Senior Medical Director, Medical Affairs</name_or_title>
      <organization>Astellas Pharma Global Development</organization>
      <email>clinicaltrials@us.astellas.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

